Does UPADACITINIB Cause Hypersensitivity? 362 Reports in FDA Database

Q: Does UPADACITINIB cause Hypersensitivity?

362 reports of Hypersensitivity have been filed with the FDA for UPADACITINIB, representing 0.6% of all UPADACITINIB adverse event reports.

Q: How dangerous is Hypersensitivity from UPADACITINIB?

Of 362 reports, 81 (22.4%) resulted in death and 138 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 362 reports of Hypersensitivity have been filed in association with UPADACITINIB (Rinvoq). This represents 0.6% of all adverse event reports for UPADACITINIB.

362

Reports of Hypersensitivity with UPADACITINIB

0.6%

of all UPADACITINIB reports

Deaths

138

Hospitalizations

How Dangerous Is Hypersensitivity From UPADACITINIB?

Of the 362 reports, 81 (22.4%) resulted in death, 138 (38.1%) required hospitalization, and 88 (24.3%) were considered life-threatening.

Is Hypersensitivity Listed in the Official Label?

Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.

What Other Side Effects Does UPADACITINIB Cause?

Pain (4,444) Arthralgia (3,815) Drug ineffective (3,384) Covid-19 (2,978) Rheumatoid arthritis (2,730) Pain in extremity (2,353) Fatigue (2,153) Fall (2,081) Surgery (2,037) Therapy interrupted (1,741)

What Other Drugs Cause Hypersensitivity?

ETANERCEPT (10,846) ADALIMUMAB (10,641) METHOTREXATE (9,799) TOCILIZUMAB (9,076) ABATACEPT (8,945) INFLIXIMAB (8,519) RITUXIMAB (8,408) ADAPALENE (8,356) LEFLUNOMIDE (7,926) CERTOLIZUMAB PEGOL (7,353)

Which UPADACITINIB Alternatives Have Lower Hypersensitivity Risk?

UPADACITINIB vs URAPIDIL UPADACITINIB vs UREA UPADACITINIB vs URIDINE TRIACETATE UPADACITINIB vs UROFOLLITROPIN UPADACITINIB vs URSODIOL

UPADACITINIB Full Profile All Hypersensitivity Reports All Drugs Causing Hypersensitivity UPADACITINIB Demographics